Blood test could end guesswork in amoxicillin allergy diagnosis
NCT ID NCT06409884
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new blood test called the T-cell activation test to see if it can more accurately diagnose amoxicillin allergy. Researchers will compare results from 300 people with suspected allergy and those without. If the test works well, it could replace less reliable skin tests and help people avoid unnecessary antibiotic avoidance.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- T-cell activation test (blood test)
- What this could lead to
- If successful, this test could provide a more reliable way to diagnose amoxicillin allergy, helping patients avoid unnecessary restrictions on antibiotic use.
- What could go wrong
- This is an early validation study, so the test may not prove accurate enough for routine use. It also requires specialized lab work, which may limit availability.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMOXICILLIN ALLERGY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Antwerp University Hospital
RECRUITINGEdegem, Antwerp, 2650, Belgium